San Diego, CA

CryoCor, Inc. (Nasdaq: CRYO) is a medical technology company specializing in the use of intracardiac cryotherapy technology. The Company is developing a family of catheter-based products that deliver cryogenic energy for creating cardiac lesions to interrupt arrhythmias, providing a curative and minimally invasive patient procedure. In July 2005, CryoCor completed its initial public offering and was acquired in June 2008.